In comparison, Mal-gluc can be a promising agent for treating depression since it is capable of penetrating across the BBB and accumulating in the brain, and that Mal-gluc selectively inhibits HDAC2 while sparing other classes of HDACs. The gene discussed is HDAC2; the disease is major depressive disorder.